Ticlopidine, Platelets and Vascular Disease

Nonfiction, Health & Well Being, Medical, Medical Science, Pharmacology, Specialties, Internal Medicine, Cardiology
Cover of the book Ticlopidine, Platelets and Vascular Disease by , Springer New York
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: ISBN: 9781461383062
Publisher: Springer New York Publication: December 6, 2012
Imprint: Springer Language: English
Author:
ISBN: 9781461383062
Publisher: Springer New York
Publication: December 6, 2012
Imprint: Springer
Language: English

Blood platelets lack a nucleus. As a result their life span is short and they cannot reproduce themselves. Platelets share these qualities with the red blood cell. Plate­ lets and red blood cells, nevertheless, serve vital roles in the body. One major function of the platelet is its capacity to aggregate and thereby initiate intravas­ cular coagulation which often underlies such major diseases as myocardial infarc­ tion, cerebral infarction, and pulmonary embolism. For this reason in recent years, medical attention has been directed to drugs that inhibit platelet aggregation. Aspirin was the first drug to be proven effective in this area. Since then other drugs that share aspirin's fundamental biochemical action, inhibition of platelet cyclooxygenase, have also been studied. Very recently, ticlopidine, the first of what promises to be a new class of drugs inhibiting platelet aggregation and coagulation via an entirely different biochemical mechanism, has been exten­ sively studied and clinically shown to be as effective or more effective than aspirin in the prevention of ischemic cardiovascular and cerebrovascular disease.

View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

Blood platelets lack a nucleus. As a result their life span is short and they cannot reproduce themselves. Platelets share these qualities with the red blood cell. Plate­ lets and red blood cells, nevertheless, serve vital roles in the body. One major function of the platelet is its capacity to aggregate and thereby initiate intravas­ cular coagulation which often underlies such major diseases as myocardial infarc­ tion, cerebral infarction, and pulmonary embolism. For this reason in recent years, medical attention has been directed to drugs that inhibit platelet aggregation. Aspirin was the first drug to be proven effective in this area. Since then other drugs that share aspirin's fundamental biochemical action, inhibition of platelet cyclooxygenase, have also been studied. Very recently, ticlopidine, the first of what promises to be a new class of drugs inhibiting platelet aggregation and coagulation via an entirely different biochemical mechanism, has been exten­ sively studied and clinically shown to be as effective or more effective than aspirin in the prevention of ischemic cardiovascular and cerebrovascular disease.

More books from Springer New York

Cover of the book Reviews of Environmental Contamination and Toxicology 196 by
Cover of the book Molecular Determinants of Radiation Response by
Cover of the book Geolocation of RF Signals by
Cover of the book RF-Frontend Design for Process-Variation-Tolerant Receivers by
Cover of the book Development and Causality by
Cover of the book From Casual Stargazer to Amateur Astronomer by
Cover of the book The Beagle Brain in Stereotaxic Coordinates by
Cover of the book Global Perspectives on Social Capital and Health by
Cover of the book Nuclear Oncology by
Cover of the book Pedophilia by
Cover of the book Creating Infrastructures for Latino Mental Health by
Cover of the book Bismuth-Containing Compounds by
Cover of the book Asymptotic Laws and Methods in Stochastics by
Cover of the book Handbook of Food Factory Design by
Cover of the book Targeted Therapies for Solid Tumors by
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy